These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 13167515)

  • 21. Central pain syndrome: elucidation of genesis and treatment.
    Canavero S; Bonicalzi V
    Expert Rev Neurother; 2007 Nov; 7(11):1485-97. PubMed ID: 17997698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the IgG index in dogs by indirect immunoenzimatic assays as diagnostic tool for inflammatory diseases of central nervous system.
    Mejías M; Molina MC; Ferreira A
    Res Vet Sci; 2008 Jun; 84(3):335-40. PubMed ID: 17716699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
    Arachchige PG; Takahashi Y; Ide T
    Metabolism; 2006 Mar; 55(3):381-90. PubMed ID: 16483883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neurological complications in Down syndrome].
    Chaanine A; Hugonenq C; Lena G; Mancini J
    Arch Pediatr; 2008 Apr; 15(4):388-96. PubMed ID: 18329863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined antiretroviral therapy and the incidence of acquired immunodeficiency syndrome-related central nervous system diseases.
    Dorrucci M; Longo B; Arpino C; Boros S; Rezza G
    Ann Neurol; 2004 Aug; 56(2):307. PubMed ID: 15293287
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies in the chemotherapy of cholera. IV. Antagonism of the antibacterial activities of 2:4-diaminopteridines, sulphaguanidine, and their mixtures.
    COLLIER HO; WATERHOUSE PD
    Ann Trop Med Parasitol; 1950 Oct; 44(3):273-80. PubMed ID: 24538829
    [No Abstract]   [Full Text] [Related]  

  • 27. Papilledema associated with dialysis disequilibrium syndrome.
    Im L; Atabay C; Eller AW
    Semin Ophthalmol; 2007; 22(3):133-5. PubMed ID: 17763231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurologic presentation in haemolytic-uraemic syndrome].
    Roche-Martínez A; Póo P; Maristany-Cucurella M; Jiménez-Llort A; Camacho JA; Campistol J
    Rev Neurol; 2008 Aug 16-31; 47(4):191-6. PubMed ID: 18671208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central nervous system involvement in Blau syndrome: a new feature of the syndrome?
    Emaminia A; Nabavi M; Mousavi Nasab M; Kashef S
    J Rheumatol; 2007 Dec; 34(12):2504-5. PubMed ID: 18061972
    [No Abstract]   [Full Text] [Related]  

  • 30. [EXPERIMENTAL STUDY ON NEUROLATHYRISM. 1. EXPERIMENTAL STUDY ON CHRONIC NEUROLATHYRISM].
    CHANG NS
    Seishin Shinkeigaku Zasshi; 1963 Jun; 65():531-8. PubMed ID: 14054653
    [No Abstract]   [Full Text] [Related]  

  • 31. [Superficial hemosiderosis of the central nervous system improved by corticosteroids].
    Le Rhun E; Soto Ares G; Pécheux N; Destée A; Defebvre L
    Rev Neurol (Paris); 2008 Mar; 164(3):264-70. PubMed ID: 18405778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult neurogenesis pharmacology in neurological diseases and disorders.
    Taupin P
    Expert Rev Neurother; 2008 Feb; 8(2):311-20. PubMed ID: 18271715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders.
    Lehmann HC; Hartung HP; Hetzel GR; Stüve O; Kieseier BC
    Arch Neurol; 2006 Jul; 63(7):930-5. PubMed ID: 16831960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome.
    Granel B; Serratrice J; Disdier P; Weiller PJ
    Rheumatology (Oxford); 2005 May; 44(5):689-90. PubMed ID: 15671048
    [No Abstract]   [Full Text] [Related]  

  • 35. Distribution and cellular localization of insulin-regulated aminopeptidase in the rat central nervous system.
    Fernando RN; Larm J; Albiston AL; Chai SY
    J Comp Neurol; 2005 Jul; 487(4):372-90. PubMed ID: 15906313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Important early symptoms in central nervous system diseases].
    Wallenberg A
    Z Arztl Fortbild Qualitatssich; 2005; 99(3):232-3. PubMed ID: 15999588
    [No Abstract]   [Full Text] [Related]  

  • 37. CNS disease as the main manifestation of hemophagocytic lymphohistiocytosis in two children.
    Rostasy K; Kolb R; Pohl D; Mueller H; Fels C; Moers AV; Bergmann M; Hanefeld F; Pekrun A; Schulz-Schaeffer W
    Neuropediatrics; 2004 Feb; 35(1):45-9. PubMed ID: 15002052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Degenerative neurological diseases of the central nervous system related to genetic neurolipidoses].
    Baumann N; Turpin JC; Lefevre M; Colsch B
    Bull Acad Natl Med; 2003; 187(1):141-51; discussion 152. PubMed ID: 14556460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Critical analysis on the semeiology of auditory disorders in relation to lesions of the central nervous system].
    AUBRY M; PIALOUX P; LUCAS A; BOUCHET J
    Presse Med (1893); 1961 Mar; 69():577-80. PubMed ID: 13685044
    [No Abstract]   [Full Text] [Related]  

  • 40. Alkyl derivatives of sulfaguanidine.
    BERGMANN F
    J Am Chem Soc; 1946 May; 68():765. PubMed ID: 21024879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.